| Total number of patients with CXR reports | 525 | 184 |
|---|
| Median age (IQR) | 30 (26–34) | 73 (69–78) |
| Gender | 196 female, 329 male | 79 female, 105 male |
| UK born | 45 (8.6%) | 13 (7.1%) |
| Pulmonary TB patients | 239 (45.5%) | 99 (53.8%) |
|
CXR changes
|
Number
|
Percentage
|
Number
|
Percentage
|
| Cavitation | 36 | 15.1 | 10 | 10.1 |
| Consolidation | 104 | 43.5 | 50 | 50.5 |
| Nodules | 39 (7 miliary) | 16.3 | 14 (4miliary) | 14.1 |
|
Lymphadenopathy
| 43 | 18.0 | 4 | 4.0 |
| Hilar | 19 | 7.9 | 4 | 4.0 |
| Mediastinal | 9 | 3.8 | – | – |
| Paratracheal | 14 | 5.9 | – | – |
|
Effusion
| 59 | 24.7 | 8 | 8.0 |
|
Zone of involvement
| | | | |
| Upper zone involvement | 118 | 49.4 | 49 | 49.4 |
| Upper and lower | 21 | 8.8 | 17 | 17.1 |
| Lower | 59 | 24.7 | 31 | 31.3 |
|
Microbiology
| | | | |
| Cultured MTB | 158 | 66.1 | 67 | 67.7 |
| Smear Positive | 56 | 23.4 | 19 | 19.1 |
| Fully sensitive | 146 | 61 | 61 | 61.6 |
| INH resistant | 7 | 2.9 | 1 | 1.0 |
| MDR | 1 | 0.4 | | |
| XDR | 1 | 0.4 | | |
|
Diabetes
| 2 | 0.8 | 28 | 28.2 |